Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
Laisheng Cai, Jingwei Huang Department of Neurology, The First Affiliated Hospital of Nanchang University, Jiangxi, People’s Republic of China Purpose: There is a need for biomarkers in multiple sclerosis (MS) to make an early diagnosis and monitor its progression. This study was designe...
Guardado en:
Autores principales: | Cai L, Huang J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cbdf575a7903489f85725f8051f941ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
por: Jia-Hung Chen, et al.
Publicado: (2021) -
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Marta Simone, et al.
Publicado: (2021) -
Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Kuo-Hsuan Chang, et al.
Publicado: (2021) -
DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS
por: V. D. Nazarov, et al.
Publicado: (2015) -
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
por: Franz Felix Konen, et al.
Publicado: (2021)